Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1985 Feb;75(2):176–177. doi: 10.2105/ajph.75.2.176

Benefit-cost analysis of active surveillance of primary care physicians for hepatitis A.

M W Hinds, J W Skaggs, G H Bergeisen
PMCID: PMC1645977  PMID: 3917619

Abstract

We identified two random samples of 216 primary care physicians each. In one sample, we made weekly telephone contact for active hepatitis A (HA) surveillance; in the other, we made no such contact (passive surveillance). Appropriate county health departments were notified whenever we identified a HA case by active surveillance. Active surveillance was associated with a 2.8-fold increase in reported HA cases compared to passive surveillance. The estimated benefit: cost ratio active/passive surveillance was 2.5:1.

Full text

PDF
176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brachott D., Mosley J. W. Viral hepatitis in Israel: the effect of canvassing physicians on notifications and the apparent epidemiological pattern. Bull World Health Organ. 1972;46(4):457–464. [PMC free article] [PubMed] [Google Scholar]
  2. Dowdle W. R. Surveillance and control of infectious diseases: progress toward the 1990 objectives. Public Health Rep. 1983 May-Jun;98(3):210–218. [PMC free article] [PubMed] [Google Scholar]
  3. Gale J. L., Hinds M. W. Male urethritis in King County, Washington, 1974-75: I. Incidence. Am J Public Health. 1978 Jan;68(1):20–25. doi: 10.2105/ajph.68.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Landrigan P. J., Huber D. H., Murphy G. D., 3rd, Creech W. B., Bryan J. A. The protective efficacy of immune serum globulin in hepatitis A: a statistical approach. JAMA. 1973 Jan 1;223(1):74–75. [PubMed] [Google Scholar]
  5. Mann J. M., Francis D. P., Hoffman R. E., Montes J. Assessment of immunoglobulin use for hepatitis A control in New Mexico. Public Health Rep. 1982 Nov-Dec;97(6):516–520. [PMC free article] [PubMed] [Google Scholar]
  6. Marier R. The reporting of communicable diseases. Am J Epidemiol. 1977 Jun;105(6):587–590. doi: 10.1093/oxfordjournals.aje.a112424. [DOI] [PubMed] [Google Scholar]
  7. Thacker S. B., Choi K., Brachman P. S. The surveillance of infectious diseases. JAMA. 1983 Mar 4;249(9):1181–1185. [PubMed] [Google Scholar]
  8. Tolsma D. D., Bryan J. A. The economic impact of viral hepatitis in the United States. Public Health Rep. 1976 Jul-Aug;91(4):349–353. [PMC free article] [PubMed] [Google Scholar]
  9. Vogt R. L., LaRue D., Klaucke D. N., Jillson D. A. Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont. Am J Public Health. 1983 Jul;73(7):795–797. doi: 10.2105/ajph.73.7.795. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES